Scaggs, I am not sure what GLE was doing in Lucas Heights, maybe Moosey can comment but I would expect the vast majority of the work on commercializing the Silex technology is being done at GE Hitachi Nuclear HQ in Wilmington. I believe the Cammeco consideration for an asset impairment is a brought on by accounting standards in relation to the delay in commercialisation (not necessarily indicative of an actual intention for the technology not progressing). If new information has come to light please share but that call doesn't concern me at all. From the information I can find it all looks business as usual except delays. Don't get me wrong, delaying commencement of Wilmington is not good news at all for Silex. It probably explains why it dropped from $2.50 to $1ish - my view is simply that after the 30th June announcement when it was around $1 not much has actually changed because we were clearly told 2019 was the target and Wilmington would only progress when commercial considerations improved. I am the iceman!
SLX Price at posting:
89.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)